The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for ibidi sales in the US from 2017 to 2023, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights ibidi GmbH, United States Revenue

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

ibidi GmbH (ibidi) is a provider of functional cell based assays and advanced products for cellular microscopy. The company provides products such as ibidi labwares, instruments and accessories, cells and reagents; software packages and image analysis systems. Its instruments and accessories comprise heating and incubation systems, ibidi pump systems, optical measurement systems, electric cell substrate impedance sensing systems and accessories. ibidi’s products are used in technical aspects of microscopy live cell imaging fluorescent markers for actin visualization, transfection, transduction, and membrane fusion, screening and wound healing and migration; and other applications. The company markets its products through its network of distributors. It has its operations in Germany and the US. ibidi is headquartered in Martinsried, Germany. Key subsidiaries of ibidi include Ramcon, Blossom Biotechnologies, In Vitro Technologies, Sciencewerke and Nippon Genetics.

The key metrics of ibidi related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2023 are shown below:

As ibidi is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as ibidi.

For a detailed understanding of the performance of ibidi, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article. 

GlobalData’s revenue report leverages GlobalData’s SKU tracker, which contains real-world, purchasing data from the US healthcare institutions.